SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form F-3 - Registration statement by foreign private issuers:
SEC Accession No. 0001140361-20-015637
Filing Date
2020-07-08
Accepted
2020-07-08 16:39:20
Documents
14

Document Format Files

Seq Description Document Type Size
1 F-3 nt10013010x1_f3.htm F-3 509807
2 EXHIBIT 5.1 nt10013010x1_ex5-1.htm EX-5.1 73633
3 EXHIBIT 5.2 nt10013010x1_ex5-2.htm EX-5.2 23371
4 EXHIBIT 23.1 nt10013010x1_ex23-1.htm EX-23.1 2060
5 log01.jpg GRAPHIC 43831
6 logo02.jpg GRAPHIC 2388
7 logo_inflarx.jpg GRAPHIC 27642
8 nt10013010x1_barchart01.jpg GRAPHIC 138001
9 nt10013010x1_barchart02.jpg GRAPHIC 168415
10 nt10013010x1_ex5-1image01.jpg GRAPHIC 1671
11 nt10013010x1_flowchart01.jpg GRAPHIC 103598
12 nt10013010x1_linechart01.jpg GRAPHIC 153118
13 nt10013010x1_linechart02.jpg GRAPHIC 179819
14 nt10013010x1_linechart03.jpg GRAPHIC 159599
  Complete submission text file 0001140361-20-015637.txt   1956033
Mailing Address WINZERLAER STR. 2 JENA 2M 07745
Business Address WINZERLAER STR. 2 JENA 2M 07745 49 3641 508180
InflaRx N.V. (Filer) CIK: 0001708688 (see all company filings)

IRS No.: 000000000 | State of Incorp.: P7 | Fiscal Year End: 1231
Type: F-3 | Act: 33 | File No.: 333-239759 | Film No.: 201018729
SIC: 2834 Pharmaceutical Preparations